medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2020, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2020; 65 (4)

Ethical issues related to planning and responding to COVID-19 pandemic

González-Fisher RF, Rissman S, Xavier G

Language: Spanish
References: 66
Page: 288-300
PDF size: 299.75 Kb.


ABSTRACT

The novel coronavirus (COVID-19) is the world’s largest public health threat, that is turning into a challenge for health systems worldwide. Planning and responding to this pandemic originate important ethical considerations related to leadership, limitation to personal freedom, the need to ration healthcare in a context of scarce resources, the use of experimental therapy and the risks that healthcare workers face.


REFERENCES

  1. Lor A, Thomas JC, Barrett DH, Ortmann LW, Herrera-Guibert DJ. Key ethical issues discussed at CDC-sponsored international, regional meetings to explore cultural perspectives and contexts on pandemic influenza preparedness and response. Int J Health Policy Manag. 2016; 5 (11): 653-662. doi: 10.15171/ijhpm.2016.55.

  2. McLean M. Ethical preparedness for pandemic influenza: a toolkit. Markkula Center for Applied Ethics. Oct 1, 2012. 12AD. Available in: www.scu.edu/ethics/focus-areas/bioethics/resources/ethical-preparedness-for-pandemic-influenza/

  3. Payne K. Ethical issues related to pandemic flu planning and response. AACN Adv Crit Care. 2007; 18 (4): 356-360.

  4. Strosberg MA. Allocating scarce resources in a pandemic: ethical and public policy dimensions. Virtual Mentor. 2006; 8 (4): 241-244.

  5. Walensky RP, Del Rio C. From mitigation to containment of the COVID-19 pandemic: putting the SARS-CoV-2 genie back in the bottle. JAMA. 2020; 323 (19): 1889-1890. doi: 10.1001/jama.2020.6572.

  6. Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. London: Imperial College COVID-19 Response Team; 2020. doi: https://doi.org/10.25561/77482, accessed 03/17/2020.

  7. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide, as of 27 November 2020. [Accessed 9/26/2020] Available in: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases

  8. Centers for Disease Control and Prevention. 2020. [Accessed 04/11/2020] Available in: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/past-reports/04172020.html

  9. Viglione G. How many people has the coronavirus killed? Nature [Internet]. 2020[accessed 09/26/2020]; 585 (7823): 22-24. doi: 10.1038/d41586-020-02497-w. Available in: https://www.nature.com/articles/d41586-020-02497-w

  10. Roos R. HHS releases new pandemic flu plan. Center for Infectious Disease Research and Policy. 2005. [Accessed 03/08/2020] Available in: https://www.cidrap.umn.edu/news-perspective/2005/11/hhs-releases-new-pandemic-flu-plan

  11. Li HO, Bailey A, Huynh D, Chan J. YouTube as a source of information on COVID-19: a pandemic of misinformation? BMJ Glob Health. 2020; 5 (5): e002604. doi: 10.1136/bmjgh-2020-002604.

  12. Pierce J, Randels G. Contemporary bioethics, a reader with cases. New York, Oxford: Oxford University Press; 2010.

  13. Department of Veterans Affairs. Meeting the ethical challenges of a severe pandemic influenza. 2010. [Accessed 03/12/2020] Available in: https://www.ethics.va.gov/docs/pandemicflu/Ethics_and_Pandemic_Flu_Fact_Sheet_508_2010-09-30.pdf

  14. Denecke K, Bamidis P, Bond C, Gabarron E, Househ M, Lau AY et al. Ethical issues of social media usage in healthcare. Yearb Med Inform. 2015; 10 (1): 137-147. doi: 10.15265/IY-2015-001.

  15. Kuy SR, Gupta R, Correa R, Tsai R, Vohra S. Best practices for a Covid-19 preparedness plan for health systems. NEJM Catal Innov Care Deliv. 2020. doi: 10.1056/CAT.20.0108.

  16. APD. ¿Qué es el entorno VUCA y cómo afecta a la supervivencia de las empresas? 2018. [Accessed 04/3/2020] Disponible en: https://www.apd.es/que-es-el-entorno-vuca-y-como-afecta-a-la-supervivencia-de-las-empresas/

  17. Korn Ferry. [accessed 04/27, 2020] Disponible en: https://www.kornferry.com/insights/articles/burnison-coronavirus-leadership-crisis

  18. Quinn P. Crisis communication in public health emergencies: the limits of ‘legal control’ and the risks for harmful outcomes in a digital age. Life Sci Soc Policy. 2018; 14 (1): 4. doi: 10.1186/s40504-018-0067-0.

  19. Kim Y. Toward an ethical model of effective crisis communication. Bus Soc Rev. 2015; 120 (1): 57-81.

  20. Giuliani RW. Leadership. New York: Miramax books; 2002.

  21. Gostin LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA. 2020; 323 (21): 2137-2138. doi: 10.1001/jama.2020.5460.

  22. Zarzaur BL, Stahl CC, Greenberg JA, Savage SA, Minter RM. Blueprint for restructuring a department of surgery in concert with the health care system during a pandemic: the University of Wisconsin Experience. JAMA Surg. 2020; 155 (7): 628-635. doi: 10.1001/jamasurg.2020.1386.

  23. Aacharya RP, Gastmans C, Denier Y. Emergency department triage: an ethical analysis. BMC Emerg Med. 2011; 11: 16. doi: 10.1186/1471-227X-11-16.

  24. Repine TB, Lisagor P, Cohen DJ. The dynamics and ethics of triage: rationing care in hard times. Mil Med. 2005; 170 (6): 505-509

  25. Iserson KV, Moskop JC. Triage in medicine, part I: Concept, history, and types. Ann Emerg Med. 2007; 49 (3): 275-281.

  26. Beauchamp TL, Childress JF. Principles of biomedical ethics. New York: Oxford University Press; 2009.

  27. Bernstein SL, Aronsky D, Duseja R, Epstein S, Handel D, Hwang U et al. The effect of emergency department crowding on clinically oriented outcomes. Acad Emerg Med. 2009; 16 (1): 1-10.

  28. Hodge AN, Marshall AP. Violence and aggression in the emergency department: a critical care perspective. Aust Crit Care. 2007; 20 (2): 61-67.

  29. Ekwall A, Gerdtz M, Manias E. The influence of patient acuity on satisfaction with emergency care: perspectives of family, friends and carers. J Clin Nurs. 2008; 17 (6): 800-809.

  30. Hartman RG. Tripartite triage concerns: issues for law and ethics. Crit Care Med. 2003; 31 (5 Suppl): S358-S361. doi: 10.1097/01.CCM.0000065130.18337.05.

  31. White DB, Lo B. A framework for rationing ventilators and critical care beds during the COVID-19 pandemic. JAMA. 2020; 323 (18): 1773-1774. doi: 10.1001/jama.2020.5046.

  32. Curtis JR, Kross EK, Stapleton RD. The importance of addressing advance care planning and decisions about do-not-resuscitate orders during novel coronavirus 2019 (COVID-19). JAMA. 2020; 323 (18): 1771-1772. doi: 10.1001/jama.2020.4894.

  33. https://www.health.pa.gov/topics/Documents/Diseases%20and%20Conditions/COVID-19%20Interim%20Crisis%20Standards%20of%20Care.pdf (accessed 12/09/2020)

  34. Miceli M. Bioethics in practice: unilateral do-not-resuscitate orders. Ochsner J. 2016; 16 (2): 111-112.

  35. Wallace CL, Wladkowski SP, Gibson A, White P. Grief during the COVID-19 pandemic: considerations for palliative care providers. J Pain Symptom Manage. 2020; 60 (1): e70-e76.

  36. Janssen DJA, Ekström M, Currow DC, Johnson MJ, Maddocks M, Simonds AK et al. COVID-19: guidance on palliative care from a European Respiratory Society international task force. Eur Respir J. 2020; 56 (3): 2002583.

  37. Fusi-Schmidhauser T, Preston NJ, Keller N, Gamondi C. Conservative management of COVID-19 patients-emergency palliative care in action. J Pain Symptom Manage. 2020; 60 (1): e27-e30.

  38. Chidiac C, Feuer D, Naismith J, Flatley M, Preston N. Emergency palliative care planning and support in a COVID-19 pandemic. J Palliat Med. 2020; 23 (6): 752-753.

  39. Kaiser Health News. Palliative care helped family face ‘the awful, awful truth’. 2020. [Accessed 05/11/2020] Available in: https://khn.org/news/palliative-care-helped-family-face-the-awful-awful-truth/

  40. Centers for Disease Control and Prevention. Cost of the Ebola epidemic. 2019. [Accessed 03/30/2020] Available in: https://www.cdc.gov/vhf/ebola/history/2014-2016-outbreak/cost-of-ebola.html

  41. Beckman AL, Gondi S, Forman HP. How to stand behind frontline health care workers fighting coronavirus. Health Affairs; 2020. [Accessed 03/30/2020] Available in: https://www.healthaffairs.org/do/10.1377/hblog20200316.393860/full/

  42. Nguyen LH, Drew DA, Graham MS, Joshi AD, Guo CG, Ma W et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health. 2020; 5 (9): e475-e483.

  43. Lazzerini M, Putoto G. COVID-19 in Italy: momentous decisions and many uncertainties. Lancet Glob Health. 2020; 8 (5): e641-e642.

  44. CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19-United States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (15): 477-481.

  45. México es el país que registra más muertes de trabajadores de salud por Covid-19. El Economista [Internet]. 03 de septiembre de 2020. [Acceso 09/26/2020] Disponible en: https://www.eleconomista.com.mx/politica/Mexico-es-el-pais-que-registra-mas-muertes-de-trabajadores-de-salud-por-Covid-19--20200903-0037.html

  46. Agren D. Understanding Mexican health worker COVID-19 deaths. Lancet. 2020; 396 (10254): 807.

  47. Shields A, Faustini SE, Perez-Toledo M, Jossi S, Aldera E, Allen JD et al. SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax. 2020; 75 (12): 1089-1094.

  48. Tay JK, Khoo ML, Loh WS. Surgical considerations for tracheostomy during the COVID-19 pandemic: lessons learned from the severe acute respiratory syndrome outbreak. JAMA Otolaryngol Head Neck Surg. 2020; 146 (6): 517-518.

  49. Buerhaus PI, Auerbach DI, Staiger DO. Older clinicians and the surge in novel coronavirus disease 2019 (COVID-19). JAMA. 2020; 323 (18): 1777-1778. doi: 10.1001/jama.2020.4978.

  50. Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. 2020; 323 (19): 1912-1914. doi: 10.1001/jama.2020.5317.

  51. NORMA Oficial Mexicana NOM-056-SSA1-1993, Requisitos sanitarios del equipo de protección personal. [Acceso 03/12/2020] Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/056ssa13.html

  52. NORMA Oficial Mexicana NOM-197-SSA1-2000, Que establece los requisitos mínimos de infraestructura y equipamiento de hospitales y consultorios de atención médica especializada. [Acceso 03/12/2020] Disponible en: http://www.salud.gob.mx/unidades/cdi/nom/197ssa10.html

  53. JUSTIA México. [Acceso 03/15/2020] Disponible en: https://mexico.justia.com/federales/leyes/ley-general-de-salud/titulo-decimo-octavo/capitulo-vi/#articulo-468

  54. Santiago Díaz ES. Proyecto de Decreto por el que se reforma el artículo 470 de la Ley General de Salud. Gaceta Parlamentaria, año XXIII; número 5502-1; 21 de abril de 2020; páginas 43-49. Cámara de Diputados LXIV Legislatura. Disponible en: https://bit.ly/2Wx96c1 (HTML) y https://bit.ly/3cML3vD (PDF).

  55. American Nurses Association. Code of ethics for nurses with interpretive statements. Washington, DC: American Nurses Association; 2001.

  56. Meagher KM, Cummins NW, Bharucha AE, Badley AD, Chlan LL, Wright RS. COVID-19 ethics and research. Mayo Clin Proc. 2020; 95 (6): 1119-1123. doi: 10.1016/j.mayocp.2020.04.019.

  57. Darrow JJ, Sarpatwari A, Avorn J, Kesselheim AS. Practical, legal, and ethical issues in expanded access to investigational drugs. N Engl J Med. 2015; 372 (3): 279-286. doi: 10.1056/NEJMhle1409465.

  58. Okie S. Access before approval--a right to take experimental drugs? N Engl J Med. 2006; 355 (5): 437-440. doi: 10.1056/NEJMp068132.

  59. Goodman JL, Borio L. Finding effective treatments for COVID-19: scientific integrity and public confidence in a time of crisis. JAMA. 2020; 323 (19): 1899-1900. doi: 10.1001/jama.2020.6434.

  60. Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020: ciaa530. doi: 10.1093/cid/ciaa530.

  61. Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect. 2020; 26 (10): 1395-1399.

  62. Beovi? B, Doušak M, Ferreira-Coimbra J, Nadrah K, Rubulotta F, Belliato M et al. Antibiotic use in patients with COVID-19: a ‘snapshot’ infectious diseases international research initiative (ID-IRI) survey. J Antimicrob Chemother. 2020; 75 (11): 3386-3390.

  63. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected interim guidance. World Health Organization website. Published May 27, 2020. [Accessed 09/26/2020] Available in: http://apps.who.int/iris/bitstream/10665/178529/1/WHO_MERS_Clinical_15.1_eng.pdf.

  64. Ison MG, Wolfe C, Boucher HW. Emergency use authorization of remdesivir: the need for a transparent distribution process. JAMA. 2020; 323 (23): 2365-2366. doi: 10.1001/jama.2020.8863.

  65. Loutfy M. Changing the rules in times of crisis: do desperate times allow desperate measures? Virtual Mentor. 2006; 8 (4): 214-218.

  66. Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020; 323 (19): 1897-1898. doi: 10.1001/jama.2020.4742.



EVIDENCE LEVEL

III




2020     |     www.medigraphic.com